Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P27 in Acute Uncomplicated Influenza A
NCT03511066Phase 2Terminated
- Sponsor
- Celltrion
- Start
- Dec 2016
- Primary completion
- Mar 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CT-P27 in Influenza A (IAV), sponsored by Celltrion. Started Dec 2016; status: terminated.
02
Drugs
CT-P27
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT03511066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03511066.